The FDA has advised doctors to limit prescriptions of the pain medications Celebrex and Bextra because some data show they may increase the risk of heart attack and stroke. Diane and her guests talk about drug safety, the FDA’s approval process and the agency’s relationship with pharmaceutical companies.

Guests

  • Dr. Paul Antony chief medical officer for the Pharmaceutical Research and Manufacturers of America
  • Dr. Janet Woodcock deputy commissioner and chief medical officer of the FDA
  • Gardiner Harris science reporter for "The New York Times"

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

New York Times Columnist David Brooks

Friday, Feb 24 2017New York Times columnist David Brooks talks with Diane about what he sees happening inside Washington and around the country and why he thinks President Trump represents the wrong answer to the right question.

Efforts to Improve The Way We Die

Friday, Feb 17 2017Diane speaks with Dr. Roger Kligler who is living with advanced stage cancer on why he's suing the state of Massachusetts for the 'Right to Die' and with Dr. Jessica Zitter, and intensive care and palliative care specialist on why better communication is so needed between doctors and patients facing end-of-life issues.

Two Weeks In: The U.S. Government Under President Trump

Friday, Feb 03 2017President Trump announces his nominee for the Supreme Court, legal battles ramp up in opposition to the Trump's executive order on immigration restrictions,and some in Congress vow to resist: Three political experts speculate on the future of our three branches of government and their respective powers in the Trump administration.